APRE swing ideaStrong support here and daily CBD formed, potential on weekly CBD RSI and MACD. Potential 4h triple CBD and 1h CBD forming. Seems strong for a push up, could push more above 3.2.
APRE
$APRE next small cap pop!!!! From a technical standpoint we are looking pretty strong as we closed about the 9-day AND the 26-day moving average with high buying pressure whicks which is interesting
Now from a company perspective standpoint we are most likely to first get approval on, this would be like the most expensive drug I have EVER heard of! In other words MEGA MEGA profit potential for APRE. So basically this would make more money per patient than any other drug in the ENTIRE cancer industry.
APREAprea Therapeutics Inc (NASDAQ:APRE) Potential breakout play. Watch the stock closely tomorrow and once it breaks $5.75, get ready to jump in and buy the stock for another swing trade. Stop 5.1
6/6 wins with a few more called out for good luck +$2233.00Hi Guys,
Took a lot of trades today. Whohoo!!!
Thanks,
Enda
APRE longnot much to describe here.
I will just give it a try with a tight stop-loss.
expecting it to fill the gap.
the drop back in dec happened because one of its clinical trials did not succeed.
but they still work on others.
APREAprea Therapeutics Inc (NASDAQ:APRE) The last few days the stock has seen increased volume and price. From a technical standpoint, the stock looks to have bottomed. It broke the falling wedge pattern and could eventually rally up to test its 100-day EMA in the coming days. In addition, MACD, RSI and ADX also indicate positive momentum. To think APRE was trading at $8.4 not long ago. This is worth watching and possibly stepping in for a trade.
APRE Technical Analysis 🧙Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
You can't beat this discount on $apreThe news that took this thing from $30+ to $4 was absolutely ridiculous. The recovery won't happen overnight but if you want a great swing trade here it is!!
APRE Technical Analysis.If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
